09:53 AM EST - Lorus Therapeutics Inc : announced that the National Research Council of Canada Industrial Research Assistance Program has awarded funding to Lorus to support development of IL-17E for cancer therapy. Lorus Therapeutics Inc
shares T.LOR are trading unchanged at $0.50.
